Skip to content
Link copied to clipboard
Link copied to clipboard

Antimalarial drug touted by Trump linked to increased risk of death in coronavirus patients, study says

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Donald Trump as a "game changer" in the fight against the virus had a significantly higher risk of death compared with those who did not.

President Donald Trump talked to reporters before departing the White House for a trip to Michigan on Thursday.
President Donald Trump talked to reporters before departing the White House for a trip to Michigan on Thursday.Read moreEvan Vucci / AP
    by Ariana Eunjung Cha and Laurie McGinley, Washington Post
    Published